A score to predict liver fibrosis

In order to better assess liver fibrosis, non-invasively and early on, researchers here have developed a new predictive score, called the LiverRisk. They evaluated the predictive performance and cost-effectiveness of the LiverRisk score for liver fibrosis and liver and diabetes-related mortality in the general population. Compared with conventional scores, the LiverRisk score had significantly better accuracy and calibration in predicting liver fibrosis. Based on this score, the researchers were able to differentiate three groups within the populations studied: low, medium and high risk. Compared to the low-risk group, the medium- and high-risk groups had a significantly higher risk of liver-related mortality and diabetes.